Australia markets open in 9 hours 37 minutes

AbbVie Inc. (ABBV)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
152.85+3.74 (+2.51%)
As of 10:23AM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 266.85B
Enterprise value 332.75B
Trailing P/E 21.67
Forward P/E 10.71
PEG ratio (5-yr expected) N/A
Price/sales (ttm)4.73
Price/book (mrq)16.39
Enterprise value/revenue 5.87
Enterprise value/EBITDA 13.45

Trading information

Stock price history

Beta (5Y monthly) 0.81
52-week change 330.00%
S&P500 52-week change 3-6.07%
52-week high 3175.91
52-week low 3105.56
50-day moving average 3157.64
200-day moving average 3132.67

Share statistics

Avg vol (3-month) 37.43M
Avg vol (10-day) 36.4M
Shares outstanding 51.77B
Implied shares outstanding 6N/A
Float 81.77B
% held by insiders 10.11%
% held by institutions 170.86%
Shares short (28 Apr 2022) 413.15M
Short ratio (28 Apr 2022) 41.52
Short % of float (28 Apr 2022) 40.75%
Short % of shares outstanding (28 Apr 2022) 40.74%
Shares short (prior month 30 Mar 2022) 413.44M

Dividends & splits

Forward annual dividend rate 45.64
Forward annual dividend yield 43.81%
Trailing annual dividend rate 35.42
Trailing annual dividend yield 33.63%
5-year average dividend yield 44.27
Payout ratio 476.18%
Dividend date 315 May 2022
Ex-dividend date 413 Apr 2022
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)30 Mar 2022

Profitability

Profit margin 22.00%
Operating margin (ttm)35.41%

Management effectiveness

Return on assets (ttm)8.55%
Return on equity (ttm)83.12%

Income statement

Revenue (ttm)56.73B
Revenue per share (ttm)32.04
Quarterly revenue growth (yoy)4.10%
Gross profit (ttm)38.88B
EBITDA 28.44B
Net income avi to common (ttm)12.41B
Diluted EPS (ttm)6.97
Quarterly earnings growth (yoy)26.40%

Balance sheet

Total cash (mrq)7.57B
Total cash per share (mrq)4.28
Total debt (mrq)73.65B
Total debt/equity (mrq)451.44
Current ratio (mrq)0.81
Book value per share (mrq)9.22

Cash flow statement

Operating cash flow (ttm)22.81B
Levered free cash flow (ttm)19.24B